Corneal toxicity reported with mirvetuximab soravtansine
by Elana GotkineFor patients receiving mirvetuximab soravtansine (MIRV) treatment for primary gynecologic malignancies, corneal toxicity is not uncommon, but usually resolves, according to a study pre
Updated on: October 30,2024
0

Corneal toxicity reported with mirvetuximab soravtansine
by Elana GotkineFor patients receiving mirvetuximab soravtansine (MIRV) treatment for primary gynecologic malignancies, corneal toxicity is not uncommon, but usually resolves, according to a study pre
Updated on:October 30,2024
0
